Table: begin end state 1 1633 non-cytoplasmic
Input: >AO353_22820 MAFFTAASKADFQQQLQAALAQHISEQSLPQVALFAEQFFGIISLDELTQRRLSDLAGCT LSAWRLLERFDHAQPQVRVYNPDYERHGWQSTHTAVEVLHHDLPFLVDSVRTELNRRGYS IHTLQTTVLSVRRGAKGELLEILPKGSQGEGILQESLMYLEIDRCAHTAELNVLSKELEQ VLSEVRVAVADFEPMKAKVQELIEGIDKSKFAVDAEEKSEIKGFLEWLVGNHFTFLGYEE FVVRDDKDGGHIEYDQSSFLGLTRLLRAGLTADDLRIEDYAVNYLREPTPLSFAKAAHPS RVHRPAYPDYVSIRQIDANGKVIKECRFMGLYTSSVYGESVRVIPYIRRKVDVIEQRSGF QSKAHLGKELAQVLEVLPRDDLFQTPVDELFSTVMSIVQIQERNKIRVFLRKDPYGRFCY CLAYVPRDIYSTEVRQKIQQVLMDRLKASDCEFWTFFSESVLARVQLILRVDPKNRLDID PLLLEKEVVQACRSWQDDYASLVVESFGEAQGTNVLSDFPKGFPAGYRERFAAHSAVVDM QHLLSLSEKNPLVMSFYQPLGQVSGQRELHCKLYHADTPLALSDVLPILENLGLRVLGEF PYRLRHSNGREFWIHDFAFTAAEGLELDIQQLNDTLQDAFVHIVRGDAENDAFNRLVLTA GLPWRDVALLRAYARYLKQIRLGFDLGYIASTLNNHTDIARELTRLFKTRFYLARKLTSD DLDDKQLRLEQAILSALDDVQVLNEDRILRRYLDLIKATLRTNFYQTDANGQNKSYFSFK FNPHAIPELPKPVPKFEIFVYSPRVEGVHLRFGNVARGGLRWSDREEDFRTEVLGLVKAQ QVKNSVIVPVGAKGGFLPRRLPLGGSRDEIAAEGIACYRIFISGLLDITDNLKDGALVPP ANVVRHDDDDPYLVVAADKGTATFSDIANGIAIDYGFWLGDAFASGGSAGYDHKKMGITA KGAWVGVQRHFRERGINVQEDSITVVGVGDMAGDVFGNGLLMSDKLQLVAAFNHLHIFID PNPQPANSFAERQRLFDLPRSAWSDYDTSIMSEGGGIFSRSAKSIAISPQMKERFDIQAD KLTPTELLNALLKAPVDLLWNGGIGTYVKASSESHADVGDKANDALRVNGNELRCKVVGE GGNLGMTQLGRVEFGLNGGGSNTDFIDNAGGVDCSDHEVNIKILLNEVVQAGDMTEKQRN QLLGSMTDEVGGLVLGNNYKQTQALSLAARRAYVRIAEYKRLMNDLEGRGKLDRAIEFLP TEDQLNERVAAGHGLTRAELSVLISYSKIDLKEQLLNSLVPDDDYLTRDMETAFPPMLVS KFSEAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSPANVAGAYVIVRDIFHL PHWFRQIEALDYQVSADVQLELMDELMRLGRRATRWFLRSRRNEQNAARDVAHFGPHLAA LGLKLDELLEGPTREGWQTRYQAYVAAGVPELLARMVAGTSHLYTLLPIIEAADVTGQNA ADVAKAYFAVGSALDLTWYLQQISALPVENNWQALAREAFRDDIDWQQRAITISVLQMGN GKQDVETRLALWMDQNQTMVERWRAMLVDIRAASGTDYAMYAVANRELLDLALSGQAVVP VTATAIAELEPAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server